Drug Profile
Research programme: Alzheimer's disease selective estrogen receptor modulators - Hormos Medical
Alternative Names: HM-144Latest Information Update: 20 Dec 2005
Price :
$50
*
At a glance
- Originator Hormos Medical
- Class
- Mechanism of Action Selective estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 20 Dec 2005 Discontinued - Preclinical for Alzheimer's disease in Finland (unspecified route)
- 16 May 2005 Hormos Medical has been acquired and merged into QuatRx Pharmaceuticals
- 14 Jul 2004 The Alzheimer's disease SERM Programme is available for licensing (http://www.hormos-med.com)